Prospective investigation of transfusion transmitted infection in recipients of over 20 000 units of blood. TTI Study Group
- PMID: 10669443
- PMCID: PMC27283
- DOI: 10.1136/bmj.320.7232.403
Prospective investigation of transfusion transmitted infection in recipients of over 20 000 units of blood. TTI Study Group
Erratum in
- BMJ 2000 Jul 29;321(7256):266
Abstract
Objectives: To follow up recipients of 20 000 units of blood to identify any transmissions of infections through blood transfusion.
Design: Follow up study of recipients of transfusion.
Setting: 22 hospitals in north London.
Participant: Adult patients who had recently been transfused.
Main outcome measures: Patients had further blood samples taken at 9 months that were tested for markers of hepatitis B and C and HIV and human T cell leukaemia/lymphoma virus type I or II (HTLV) infections. Recent infections were distinguished from pre-existing infections by comparison with blood samples taken before transfusion.
Results: 9220 patients were recruited, and 5579 recipients of 21 923 units of blood were followed up. No transfusion transmitted infections were identified. The incidence of transfusion transmitted infections was 0 in 21 043 units (95% confidence interval for risk 0 to 1 in 5706 recipients) for hepatitis B; 0 in 21 800 units (0 to 1 in 5911 recipients) for hepatitis C; 0 in 21 923 units (0 to 1 in 5944 recipients) for HIV; and 0 in 21 902 units (0 to 1 in 5939 recipients) for human T cell leukaemia/lymphoma virus. Three patients acquired hepatitis B during or after hospital admission but not through transfusion; 176 (3%) had pre-existing hepatitis B infection. Sixteen (0.29%) patients had hepatitis C, and five (0.09%) had human T cell leukaemia/lymphoma virus.
Conclusions: The current risk of transfusion transmitted infections in the United Kingdom is very small, though hospital acquired infections may arise from sources other than transfusion. A considerable proportion of patients have pre-existing infections.
Figures
Comment in
-
Transfusion transmitted infection. Did authors systematically underestimate risks of transfusion?BMJ. 2000 Sep 16;321(7262):704-5. BMJ. 2000. PMID: 11202937 Free PMC article. No abstract available.
Similar articles
-
Epidemiology of transfusion-transmitted infections among multi-transfused patients in seven hospitals in Peru.J Clin Virol. 2005 Dec;34 Suppl 2:S61-8. doi: 10.1016/s1386-6532(05)80036-8. J Clin Virol. 2005. PMID: 16461242
-
Transfusion-transmitted infections among multi-transfused patients in Brazil.J Clin Virol. 2005 Dec;34 Suppl 2:S27-32. doi: 10.1016/s1386-6532(05)80031-9. J Clin Virol. 2005. PMID: 16461237
-
An estimate of the current risk of transmitting blood-borne infections through blood transfusion in Italy.Br J Haematol. 2002 Apr;117(1):215-9. doi: 10.1046/j.1365-2141.2002.03334.x. Br J Haematol. 2002. PMID: 11918558
-
Current viral risks of blood and blood products.Ann Med. 2000 Oct;32(7):469-74. doi: 10.3109/07853890009002022. Ann Med. 2000. PMID: 11087167 Review.
-
The risks of transfusion-transmitted infection: direct estimation and mathematical modelling.Baillieres Best Pract Res Clin Haematol. 2000 Dec;13(4):631-49. doi: 10.1053/beha.2000.0104. Baillieres Best Pract Res Clin Haematol. 2000. PMID: 11102281 Review.
Cited by
-
Anemia and blood transfusions in critically ill patients.J Blood Transfus. 2012;2012:629204. doi: 10.1155/2012/629204. Epub 2012 Oct 4. J Blood Transfus. 2012. PMID: 24066259 Free PMC article. Review.
-
Occult hepatitis B: clinical viewpoint and management.Hepat Res Treat. 2013;2013:259148. doi: 10.1155/2013/259148. Epub 2013 Mar 4. Hepat Res Treat. 2013. PMID: 23533738 Free PMC article.
-
Prevalence, incidence and residual risk of transfusion-transmitted hepatitis C virus and human immunodeficiency virus after the implementation of nucleic acid testing in Italy: a 7-year (2009-2015) survey.Blood Transfus. 2018 Sep;16(5):422-432. doi: 10.2450/2018.0069-18. Epub 2018 Jun 26. Blood Transfus. 2018. PMID: 30036178 Free PMC article.
-
Efficacy and Safety of Artiss Fibrin Tissue Sealant Use in Rhytidectomy: A Review of 120 Cases.Surg J (N Y). 2017 Apr 7;3(2):e69-e74. doi: 10.1055/s-0037-1599237. eCollection 2017 Apr. Surg J (N Y). 2017. PMID: 28825024 Free PMC article.
-
Prevalence of antibody to hepatitis B surface antigen among qualified blood donors in Nanjing, China.Hum Vaccin Immunother. 2023 Dec 31;19(1):2206774. doi: 10.1080/21645515.2023.2206774. Hum Vaccin Immunother. 2023. PMID: 37103976 Free PMC article.
References
-
- Contreras M, Barbara JAJ, Anderson CC, Ranasinghe E, Moore C, Brennan MT, et al. Low incidence of non-A, non-B post transfusion hepatitis in London confirmed by hepatitis C virus serology. Lancet. 1991;30:753–757. - PubMed
-
- Cohen ND, Munoz A, Reitz BA, Ness PK, Frazier OH, Yawn DH, et al. Transmission of retroviruses by transfusion of screened blood in patients undergoing cardiac surgery. N Engl J Med. 1989;320:1172–1176. - PubMed
-
- Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. N Engl J Med. 1996;334:1685–1690. - PubMed
-
- Alter H J. New kit on the block: evaluation of second generation assays for detection of antibody to the hepatitis C virus [editorial; comment] Hepatology. 1992;15:350–353. - PubMed
-
- Contreras M, Barbara J. Transfusion transmitted infections and their impact on virology. Current Med Lit (RSM) Virol. 1993;4:67–72.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical